Stockscreener 앱 받기
244.67
1.49%
-3.71
시간 외 거래:
244.67
전일 마감가:
$248.38
열려 있는:
$247.58
하루 거래량:
757.99K
Relative Volume:
1.20
시가총액:
$17.18B
수익:
$1.98B
순이익/손실:
$420.90M
주가수익비율:
41.90
EPS:
5.84
순현금흐름:
$218.20M
1주 성능:
-5.78%
1개월 성능:
-13.27%
6개월 성능:
+4.62%
1년 성능:
+39.38%
1일 변동 폭
$239.88
$247.58
1주일 범위
$230.05
$260.91
52주 변동 폭
$160.19
$289.46
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
PODD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
244.67 | 17.18B | 1.98B | 420.90M | 218.20M | 5.84 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-06 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-07 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
When the Price of (PODD) Talks, People Listen - Stock Traders Daily
Keybank National Association OH Purchases Shares of 840 Insulet Co. (NASDAQ:PODD) - Defense World
SBI Securities Co. Ltd. Buys New Shares in Insulet Co. (NASDAQ:PODD) - Defense World
Jones Financial Companies Lllp Grows Position in Insulet Co. (NASDAQ:PODD) - Defense World
Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease - Yahoo Finance
Insulet to Host Investor Day on June 5, 2025 - 01Net
Insulet Investor Day 2025: Inside the Future of Tubeless Insulin Pump Technology - StockTitan
Insulet Corp extends deal with NXP USA, amends terms - Investing.com India
Insulet Corp extends deal with NXP USA, amends terms By Investing.com - Investing.com South Africa
Smartleaf Asset Management LLC Purchases 108 Shares of Insulet Co. (NASDAQ:PODD) - Defense World
Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth - Yahoo Finance
Insulet (NASDAQ:PODD) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World
Mutual of America Capital Management LLC Trims Stock Holdings in Insulet Co. (NASDAQ:PODD) - Defense World
Insulet Corporation to Host Earnings Call - ACCESS Newswire
Insulet Co. (NASDAQ:PODD) Receives $289.06 Consensus Target Price from Analysts - Defense World
RBC Capital Initiates Coverage of Insulet (LSE:0ADR) with Outperform Recommendation - Nasdaq
RBC Capital sets Insulet stock Outperform with $340 price target By Investing.com - Investing.com South Africa
RBC Capital Initiates Coverage of Insulet (PODD) with Outperform Recommendation - Nasdaq
RBC Capital sets Insulet stock Outperform with $340 price target - Investing.com
RBC Initiates Insulet at Outperform With $340 Price Target -March 06, 2025 at 05:54 am EST - Marketscreener.com
Insulet Co. (NASDAQ:PODD) Holdings Lowered by Truist Financial Corp - Defense World
Insulet Corporation: Leveraging Direct-to-Consumer Channels To Boost Product Awareness & Usage! - Smartkarma
Insulet Co. (NASDAQ:PODD) Sees Large Decrease in Short Interest - Defense World
Insulet (NASDAQ:PODD) & PAVmed (NASDAQ:PAVM) Head-To-Head Review - Defense World
Y Intercept Hong Kong Ltd Reduces Holdings in Insulet Co. (NASDAQ:PODD) - Defense World
What's Driving the Market Sentiment Around Insulet? - Benzinga
Guru Fundamental Report for PODD - Nasdaq
Insulet Sales Keep Rising - FX Empire
Insulet May Face Choice: $452M Award Or Stifling Rival - Law360
Insulet Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Insulet Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
Bernstein raises Insulet stock price target to $335 from $315 By Investing.com - Investing.com Nigeria
Agree To Buy Insulet At $270, Earn 11% Annualized Using Options - Nasdaq
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today - Benzinga
Bernstein raises Insulet stock price target to $335 from $315 - Investing.com India
Insulet Corporation (PODD) PT Raised to $335 at Bernstein; 'Strong Q4, Great Setup for 2025' - StreetInsider.com
Redburn Atlantic Adjusts Price Target on Insulet to $315 From $300, Keeps Buy Rating - Marketscreener.com
Bernstein Adjusts Price Target on Insulet to $335 From $315, Keeps Outperform Rating - Marketscreener.com
Insulet targets 16%-20% U.S. Omnipod growth for 2025 with expanded type 2 diabetes market reach - MSN
Insulet’s Revenue Surpasses $2 Billion with Strong Growth - TipRanks
Insulet Q4 2024 revenue up 17.2% to USD 597.5M - Medical Buyer
Insulet Stock: Aiding Patients And Investors (NASDAQ:PODD) - Seeking Alpha
Insulet Earnings: What To Look For From PODD - MSN
Insulet’s Earnings Highlight Omnipod Success Amid Challenges - TipRanks
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst - AOL
Insulet Updates Equity Agreements for Fiscal 2025 - TipRanks
Insulet stock price target raised to $293 by Stifel - Investing.com Canada
Wells Fargo Adjusts Insulet Price Target to $322 From $305 -February 21, 2025 at 09:22 am EST - Marketscreener.com
Citigroup Adjusts Insulet Price Target to $355 From $310 -February 21, 2025 at 09:21 am EST - Marketscreener.com
Stifel Nicolaus Adjusts Insulet Price Target to $293 From $245 -February 21, 2025 at 09:21 am EST - Marketscreener.com
BTIG Research Adjusts Insulet Price Target to $310 From $300 -February 21, 2025 at 09:19 am EST - Marketscreener.com
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.40%
0.89%
자본화:
|
볼륨(24시간):